Steven Petrosino, Phd., Lt. Col. Usmc (Retired) Email and Phone Number
Steven Petrosino, Phd., Lt. Col. Usmc (Retired) work email
- Valid
- Valid
- Valid
Steven Petrosino, Phd., Lt. Col. Usmc (Retired) personal email
Steven Petrosino, Phd., Lt. Col. Usmc (Retired) phone numbers
Overview of qualifications: • 36 years Pharma Experience (1986-2022) • 22 years Biologics Experience (2000-2022) • 22 years experience as a Medical Science Liaison and Clinical Scientist (2000-2022) • 27 years experience in the rheumatology space. (Attended ACR 1995-present; EULAR 2003, 2004, 2006, 2007, 2009, 2012, 2015; EuroLupus 2012)• Medical writing, editing and publishing experience • Life cycle management experience with oncology products for both hematologic malignancies and solid tumors. • Life cycle management experience with rheumatology, dermatology, hematology, and gastroenterology biologic products for RA, PsO, PsA, CD, and UC. • Management designate associate (Aventis) • 29 years Management experience as a senior officer (Lt. Col.) in the US Marine Corps (1975-2004) • 35 years experience developing KOL (Key Opinion Leader) relationships in rheumatology, cardiology, gastroenterology, infectious disease, oncology, hematology, urology, and dermatology in Ohio, Pennsylvania, Upstate New York, Indiana, Illinois, Missouri, West Virginia, Minnesota, Iowa, Nebraska, Arkansas, Wisconsin, Michigan, Kentucky, and eastern Canada. (1986-present) • 26 Years Experience developing TL relationships in rheumatology, including long-term rheumatology and nephrology thought leader relationships at the University of Michigan, Henry Ford, University of Rochester, UPMC, University of Cincinnati, Ohio State University, University of Pittsburgh, University of Kentucky, Indiana University, and the Cleveland Clinic. • 4 years Oncology Experience (Aventis, Centocor, and Incyte) • 21 years experience as an MSL in Biotech Immunology (Remicade, Simponi, Stelara, Benlysta, Orencia)
-
Diamond DistributorImmunotecDublin, Oh, Us -
Member, Medical Advisory Board, Neumi LlcNeumi Jun 2022 - PresentMurray, Utah, Us -
Gold Director And Director Of Lifepharm Medical Advisory BoardLifepharm Global Network Sep 2011 - PresentIrvine, California, UsLifePharm Global is a Network marketing company that markets Laminine®, a natural, synergistic super food from organic fertilized free-range hen's eggs that contains precursors for Laminin, an essential somatic molecule that plays a critical role in cellular structure and function; provides a spectrum of all 22 amino acid precursors for Laminin; and supplies Fibroblastic Growth Factor (or FGF) - the transport mechanism needed to direct nutritional building blocks to areas of greatest cellular need. Laminine is exclusively marketed through a team of distributors belonging to the LifePharm Global Network. All-Natural Laminine is believed to be the only known nutritional source of active FGF in adults. Research suggests FGF improves neuronal function, increases amino acid and oligopeptide absorption and utilization by the cells, and supports and facilitates stem cell repair of bodily tissues and organs. FGF reprograms adult stem cells and directs the function and utilization of amino acids in the body, in the areas that most need this support. Laminine has has been clinically proven to increase serotonin while reducing detrimental levels of cortisol. Regular use of Laminine may reduce signs of aging, build collagen for healthier looking skin, stimulate natural DHEA and reduce cortisol to reduce physical & mental stress, increase physical, mental & emotional strength, promote more restful sleep, increase libido in both men and women, produce quicker recovery after work out, increase muscle tone, elevate serotonin levels to raise your mood, down-regulate pain receptors in the body, increase alertness, improve stamina and energy, aid in brain function and activity including focus, and develop an overall sense of better well-being. As a Gold Director, I lead an organization of over 2,000 distributors. Website: www.SoaringEagles.com -
Diamond DistributorImmunotec Jan 1999 - PresentThe Woodlands, Texas, UsImmunotec is a networking company that markets Immunocal, a bioactive whey protein manufactured from raw organic milk. It is the only nutritional supplement listed for the past 12 years in the Physician's Desk Reference for Drugs, although available without prescription. Immunocal is reimbursed by Medicare and Medicaid in 18 states, andl is supported by 33 published clinical studies and medical review papers and backed by over $10,000,000.00 of research. It has 77 International patents, 8 of which are US pharmaceutical method of use patents in the treatment of cancer, HIV/AIDS, and in immune system enhancement.Research on Immunocal spans 30+ years, beginning at McGill University in Montreal, Canada. Immunotec scientists were the first to describe the effects of a bioactive non-pasteurized whey protein on the immune system; were the first to show that bioactive whey protein increased the levels of a critical antioxidant called glutathione in humans; were the first to discover the effect of glutathione on the immune system in a living organism; were the first to discover that HIV-infected patients have abnormally low glutathione levels; were the first to discover the age-related decrease in the plasma concentration of cysteine, the limiting precursor of glutathione; and were the first to show in a placebo-controlled clinical trial the health benefits of an undenatured whey protein in cancer patients. Current studies have been conducted in the area of cancer, cancer cacexia (wasting), HIV/AIDS, small cell lung cancer, lung disease including cystic fibrosis & COPD, chronic fatigue syndrome (CFIDS), and autism.Dr. Luc Montagnier, 2008 Nobel Prize in Medicine recipient, based his scientific conclusions for his work on HIV, AIDS and cancer on the efficacy of Immunocal. Immunocal is the only natural product clinically proven to raise glutathione (GSH) at the cellular level.As a Diamond Distributor, I lead an organization of over 2,500 networkers & customers. -
PresidentNutrition Advisor Llc Jan 1997 - PresentDublin, Ohio, UsNutrition Advisor LLC is an automated website offering nutrition education and is a compendium and resource for credentialed nutrition advisors nationwide, offering a limited amount of selected nutritional products since 1997. Nutrition Advisor (TM), (previously Nutrition Advisor Enterprises) is wholly owned and operated by veterans (U.S. Marines and U.S. Army), and was established over 24 years ago (January 1997) by Lt. Col. Steven Petrosino, USMC (Retired). We are located in Dublin Ohio, (a Northwest suburb of Columbus Ohio). The website was an offshoot of his Dissertation and his Doctoral project, an enormous database on nutritional supplements called "The Interactive Nutritional Supplement Advisor" which was originally submitted for copyright in 1994. This database examined nutritional supplements and herbs and their clinically-proven benefits, their safety and toxicities, and their interactions with prescription medications. -
Katherine G Weissman Senior Science Fellow, Ohio ChapterChildrens Health Defense, Arizona Chapter Jan 2022 - Jul 2023Scientific writing, scientific editing, research and analysis.https://childrenshealthdefense.org/defender/chd-steven-p-petrosino-katherine-g-weisman-fellow/ -
Senior Medical Science LiaisonBristol-Myers Squibb Jun 2013 - Dec 2022Lawrence Township, Nj, UsAs Senior MSL I was responsible for establishing frequent and timely interactions with Thought Leaders (TL) and other Health Care Providers (HCP) aligned with medical strategies to discuss safe and appropriate use of approved products, and pharmacoeconomic data.Other job criteria included: Respond to unsolicited questions on current medical and scientific issues, healthcare advances, treatment trends, and health outcomes measures. TLs may include nationally and regionally recognized scientific and clinical leaders, medical advisors to managed care providers and committees, and HCPs active in addressing patient advocacy issues. Demonstrate in-depth knowledge of the assigned disease and therapeutic area(s) and key publications. Translate this information and data into high quality medical dialogue. Possess a sophisticated understanding of the pharmaceutical and healthcare industry including commercial, and government payer strategies, and the evolving healthcare delivery models. Deliver presentations to health care decision makers responding to unsolicited questions using relevant and approved materials. Support company-initiated trials (Phase II, III, IV) by interacting with primary investigators, assisting in site identification and screenings, and delivering disease education using approved resources. Support data generation activities including participating in reviews of Investigator initiated proposals (IIS, or IST). Other activities include identification and training of contracted speakers or internal team members if aligned with medical plan and product life cycle needs. Identify, collect and communicate insights to address competitive medical information in addition to insights on trends and changes affecting the regulatory and payer environment used to develop medical strategies. Fully comply with all company policies and applicable laws, regulations and ethical standards -
National Core Team Leader For Team Development"Run Ben Run" National Committee To Draft Ben Carson For President Apr 2014 - Jul 2016In this volunteer position, I served as National Team Leader, identifying and training leaders for the "Run Ben Run" Campaign. The "National Draft Ben Carson for President Committee" (Run Ben Run or RBR) was founded by John Philip Sousa IV, a great grandson of famed musician John Philip Sousa. The RBR Committee served as the primary fundraiser for a potential campaign by Dr. Carson, At the end of June 2014, our Draft Committee reported that it had raised over $7 million from 91,000 donors.In October 2014 RBR out-fundraised the pro-Hillary Clinton PAC Ready for Hillary in the third quarter of 2014, In January 2015, an Iowa poll by the Des Moines Register showed Dr. Ben Carson in second place among all potential 2016 candidates, (only behind Mitt Romney). By December, 2014, the RBR Committee had raised $13 million, Our Draft Carson Committee had chairmen in all of Iowa's 99 counties, where Dr. Carson was polling in second place, and Dr. Carson captured first place in two separate Public Policy polls for the state of Pennsylvania. The National Draft Ben Carson for President Committee helped make Dr. Ben Carson the first candidate successfully drafted for president since 1964.Much of our Committee's success in drafting Dr. Ben Carson for president can be attributed to the bottom-up online fundraising strategy we pioneered under the directorship of Ron Robinson. Our strategy utilized tech-savvy volunteers who we tasked with following up with donors and prospective donors. This authentic interaction between donors and follow-up volunteers fueled online fundraising and the momentum for a prospective Dr. Ben Carson candidacy.
-
Medical Science LiaisonIncyte Sep 2012 - Apr 2013Wilmington, Delaware, UsIncyte Corporation is a drug discovery and development company that focuses on creating proprietary small molecules to treat cancer, inflammation, and diabetes. The company's products include INCB18424 (Oral), Ruxolitinib, Jakafi (TM), which has been FDA approved for the treatment of myelofibrosis, and post-polycythemia vera (PV) or essential thrombocythemia (ET) myelofibrosis. Ruxolitinib is being studied in the treatment rheumatoid arthritis, in PV or ET, in leukemia and CML, large B-Cell or peripheral T-Cell NHL, breast cancer, pancreatic cancer, & multiple myeloma; Ruxolitinib (Topical), is in Phase IIb for the treatment of plaque psoriasis; and INCB28050, is in Phase I for the treatment of rheumatoid arthritis. Incyte's products also include INCB13739, in a Phase IIb for the treatment of Type 2 Diabetes; and INCB20817, in Phase I for the treatment of Type 2 Diabetes. Incyte’s products also include INCB7839 in Phase IIa for the treatment of solid tumors, and Phase II for the treatment of breast cancer; INCB19602 in Phase IIa for the treatment of Type 2 Diabetes; INCB8696 in Phase I for the treatment of multiple sclerosis; INCB9471 in Phase II for the treatment of HIV; and INCB15050 in Phase I for the treatment of HIV. I was contracted to Incyte through Zipher LLC. As Midwest Medical Science Liaison, I provided scientific and field medical support for a marketed product, Jakafi (ruxolitinib), a JAK I/II inhibitor indicated for the treatment of patients with intermediate or high risk myelofibrosis, including primary myelofibrosis and myelofibrosis arising in patients with polycemia vera or essential thrombocythemia.Territory included 7 states: Ohio, Indiana, Kentucky, West Virginia, Western Pennsylvania, Missouri, and Upstate New York.I provided Medical Affairs support for pipeline agents, including site identification and evaluation for clinical development studies. Therapeutic areas included myelofibrosis, polycythemia vera, and essential thrombocythemia. -
Medical Science Liaison, Educational Science LiaisonZipher Medical Affairs Co., Llc Sep 2012 - Apr 2013Zipher Medical Affairs Co., LLC is a contract medical affairs organization specializing in the therapeutic area of oncology. The company provides medical affairs consulting, services and trained medical science liaisons to support biopharmaceutical and diagnostic companies. Zipher's services are designed to integrate all aspects of the medical affairs profession; medical strategy, medical information, field medical liaisons, medical and scientific communications and clinical trial expertise to improve the results of Medical Affairs activities. As a Medical Science Liaison and Educational Science Liaison (ESL) I provide scientific and field medical support for FDA approved marketed products, including Jakafi (ruxolitinib, Incyte Corporation), a JAK I/II inhibitor indicated for the treatment of patients with intermediate or high risk myelofibrosis, including primary myelofibrosis and myelofibrosis arising in patients with polycemia vera or essential thrombocythemia.Additional responsibilities include: Provide leadership, direction, and scientific input in Medical Advisory Boards, provide scientific writing, teaching (education), scientific training, creation of scientific white papers, and scientific manuscript editing as required..My current territory includes 7 states: Ohio, Indiana, Kentucky, West Virginia, Western Pennsylvania, Missouri, and Upstate New York, but is not limited to these states.I provide Medical Affairs support for pipeline agents, including site identification and evaluation for clinical development studies.Therapeutic areas currently include myelofibrosis, polycythemia vera, and essential thrombocythemia, but is limited to oncology.
-
Senior Medical Science LiaisonHuman Genome Sciences Jan 2011 - Sep 2012Rockville, Md, UsResponsible for a four-state territory, including Ohio, Central and Western Pennsylvania, West Virginia, and Upstate New York. Responsible for Identifying, establishing and maintaining collaborative relationships with key investigators, thought leaders, and institutions within my 4-state area. Launched Benlysta® after FDA approval on March 10, 2011. Provide regular support and education to health care professionals and key opinion leaders (KOLs) concerning Lupus disease state awareness and HGS’s products. Facilitate and support Phase III and IV clinical trials, and investigator initiated research studies (IIS) of proprietarycompounds consistent with HGS objectives. Identify scientific communication opportunities including abstracts, manuscripts, and CME programs. Train sales colleagues and provide support to the sales organization. In the former capacity, created 3 training modules on lupus nephritis, and delivered a series of training programs to my medical affairs colleagues. During an 8-month collaboration with GSK Medical Affairs and Elsevier Medical Publishing, created a Lupus Image Bank, a database of over 5,000 lupus images, (www.lupusimages.com). Provide professional medical representation and support at national, regional and international sales meetings. Assist in the identification, evaluation, and screening of qualified research sites (Phase III, and IV) for clinical investigations. Medical affairs team category lead at several national and international meetings, including EuroLupus, EULAR, 2012 and ACR 2011. Made over 30 presentations to Managed care pharmacists and Medical Directors from the launch of Benlystra in March 2011 through August 2012. Responsible for understanding and abiding by OIG/ Pharma (PhRMA) code guidelines. Recognized as top MSL of all HGS MSLs for superior field presence and account activities by both senior Medical Affairs leadership and senior sales colleagues, and received this award in August 2011. -
Principal Clinical Scientist (Retired)Centocor Ortho Biotech Inc May 2000 - Jan 2011UsRetired as most senior field MSL.Covered up to 12-States and eastern Canada. Built advocacy with 100+ National Thought Leaders in the field of rheumatology, gastroenterology, pulmonology, dermatology, cardiology, nephrology, and oncology. Attended national and regional scientific meetings (ASCO, ASH, ACR, EULAR, ACG, DDW, FOCIS). Primary field liaison for Investigator-initiated studies, phase III, IIIb, and IV clinical trials, regional and national speaker development and training, & marketing advisory boards.Selected to train Schering Canada sales force and Schering MSLs on Infliximab (Remicade) and on Immunology. Created bi-weekly scientific newsletter for the President, Centocor, with copies to medical affairs, and senior sales and marketing. Newsletter followed 41 molecular entities in Phase II or later in RA, PsA, AS, CD, UC, and PsO. Received Johnson & Johnson Standards of Leadership award for this in September, 2006.Worked for 10 months with a team of 12 Johnson and Johnson scientists, MSLs, and physicians on the creation of MEDVERSATION.COM, the largest online resource in the world to support informed medical conversations between physicians & patients on autoimmune diseases, the benefits & risks of treatments, & therapeutic options. MEDVERSATION® provides links to thousands of published studies, resources from the National Library of Medicine, FDA, and links to resources about the regulation, use, benefits, and risks of drugs. Authored, researched, & created white papers. Developed online modules on Natural History of Rheumatoid Arthritis (RA), & Conventional Therapies for RA. Received the Johnson & Johnson Standards of Leadership award for this project in January 2008.Collaborated with Muhammad Khan, MD to create BASDAI.com, an online resource to allow physicians and their patients to accurately calculate a BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) score to be used in clinical research, or in patient care and management. -
Lt. Col Usmc (Retired)United States Marine Corps Mar 1975 - Nov 2004Washington, Dc, UsLt. Col., United States Marine Corps Reserve; Assistant Director of Reserve Aviation Operations, Marine Forces Atlantic Command, Norfolk, VA. June 1997-November 7, 2004. Retired November 7, 2004, following 29 years of service as a senior staff officer (Assistant Director of Reserve Aviation Operations), as a senior pilot and instructor (AH-1 TOW Cobra Attack helicopter). Graduate of the National Defense University (Washington DC) and Command and Staff College. Military awards Include: Strike-Flight Air Medal (with Gold Star in lieu of second award); Navy Commendation Medal; Navy Achievement Medal (with Gold Star in lieu of second award); Combat Action Ribbon; Navy Unit Commendation Ribbon (2 awards); Marine Unit Commendation Ribbon (2 awards); Selected Marine Corps Reserve Medal (with “M” device); Marine Corps Expeditionary Medal (2 awards); Armed Forces Expeditionary Medal; National Defense Medal; Humanitarian Services Medal (2 awards); Military Outstanding Volunteer Service Medal; Sea Service Deployment Ribbon (with two stars in lieu of additional awards); Arctic Service Ribbon; Navy and Marine Corps Over Seas Service Ribbon; Marine Recruiting Ribbon; Armed Forces Reserve Medal; Commendation from the Commandant of the Marine Corps; Four Commanding Generals' Certificates of Commendation; Fleet Commander Letter of Commendation; Six Commanding Officers' Letters of Appreciation; Rifle Expert Award (six awards); Pistol Expert Award (five awards); Naval Flight School Academic Salutatorian. -
Cardiovascular, Oncology And Rheumatology Executive Clinical Science ConsultantSanofi-Aventis Dec 1986 - Apr 2000Paris, France, Fr1996-2000: One of 50 original members of a specialized clinical and scientific sales force (a group comprising the top 5% of the Aventis sales force) tasked with launching all new Aventis drugs and establishing field training and educational programs. Responsible for Ohio Teaching hospitals, and for Ohio Field-based oncologists, urologists, cardiologists, and rheumatologists. Promoted to Management Designated Associate.1987-1996: Executive Sales Representative. Responsible for independent, entrepreneurial approach to specialty sales market, and the launch of 4 new drugs to cardiologists and nephrologists within an extensive tri-state territory (Michigan, Ohio, Kentucky). Coordinated, organized, or managed over 300 physician professional education programs, (over 5 times the company average). Participated in team building and support of 35 field and hospital representatives in four sales districts (Toledo, Columbus, Cincinnati, and Ohio Institutional). Nominated for Cardiovascular Sales Specialist of the Year for 1992, 1994, 1995, and 1996. Received 8 "top 10%" ring awards (in the 9 eligible years through 1996); awarded membership in the top sales achievement club (1996-2000). Elected club Vice President(1997), and President (1998). Won award for submitting a business suggestion that saved the company over $200,000.00. Created and developed a computer database for the Ohio Sate University Department of medicine. Designed, developed, and supervised a community-based risk factor assessment and screening program that was established at the Ohio State University Medical Clinics, and adopted by the American Red Cross (BP Links Coalition), and the American Heart Association (Inner City Minority Screening Initiative). This program benefited the community while increasing access to important minority physicians. Participated in the establishment of the HMR award to the outstanding Ohio cardiologist (Ohio ACC).
Steven Petrosino, Phd., Lt. Col. Usmc (Retired) Skills
Steven Petrosino, Phd., Lt. Col. Usmc (Retired) Education Details
-
National Defense UniversityNational Security Policy Studies -
Command And Staff CollegeNon-Profit/Public/Organizational Management -
Walden UniversityPublic Health -
Lasalle UniversityNutrition Sciences -
Penn State University3.77 Gpa)
Frequently Asked Questions about Steven Petrosino, Phd., Lt. Col. Usmc (Retired)
What company does Steven Petrosino, Phd., Lt. Col. Usmc (Retired) work for?
Steven Petrosino, Phd., Lt. Col. Usmc (Retired) works for Immunotec
What is Steven Petrosino, Phd., Lt. Col. Usmc (Retired)'s role at the current company?
Steven Petrosino, Phd., Lt. Col. Usmc (Retired)'s current role is Diamond Distributor.
What is Steven Petrosino, Phd., Lt. Col. Usmc (Retired)'s email address?
Steven Petrosino, Phd., Lt. Col. Usmc (Retired)'s email address is st****@****orm.com
What is Steven Petrosino, Phd., Lt. Col. Usmc (Retired)'s direct phone number?
Steven Petrosino, Phd., Lt. Col. Usmc (Retired)'s direct phone number is +161426*****
What schools did Steven Petrosino, Phd., Lt. Col. Usmc (Retired) attend?
Steven Petrosino, Phd., Lt. Col. Usmc (Retired) attended National Defense University, Command And Staff College, Walden University, Lasalle University, Penn State University.
What are some of Steven Petrosino, Phd., Lt. Col. Usmc (Retired)'s interests?
Steven Petrosino, Phd., Lt. Col. Usmc (Retired) has interest in Website Creation, Weightlifting, Science, Science And Technology, Database Management, Bicycling, Health.
What skills is Steven Petrosino, Phd., Lt. Col. Usmc (Retired) known for?
Steven Petrosino, Phd., Lt. Col. Usmc (Retired) has skills like Infectious Diseases, Clinical Trials, Diabetes, Oncology, Rheumatology, Clinical Development, Biotechnology, Cardiology, Clinical Research, Dermatology, Managed Care, Healthcare.
Who are Steven Petrosino, Phd., Lt. Col. Usmc (Retired)'s colleagues?
Steven Petrosino, Phd., Lt. Col. Usmc (Retired)'s colleagues are Miriam M., Cristina Morales, Keny Ramírez, Laura Ramirez, Dorothy Bosch, Alejandro Martinez, Cesar Rodriguez.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial